OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
Trang Nguyen, Yiru Zhang, Enyuan Shang, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 7, pp. 3699-3716
Open Access | Times Cited: 150
Trang Nguyen, Yiru Zhang, Enyuan Shang, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 7, pp. 3699-3716
Open Access | Times Cited: 150
Showing 1-25 of 150 citing articles:
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
M. Janaki Ramaiah, Anjana Devi Tangutur, M. Rajasekhar Reddy
Life Sciences (2021) Vol. 277, pp. 119504-119504
Closed Access | Times Cited: 219
M. Janaki Ramaiah, Anjana Devi Tangutur, M. Rajasekhar Reddy
Life Sciences (2021) Vol. 277, pp. 119504-119504
Closed Access | Times Cited: 219
Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism
Pavan S. Upadhyayula, Dominique Higgins, Angeliki Mela, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 89
Pavan S. Upadhyayula, Dominique Higgins, Angeliki Mela, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 89
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 86
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 86
Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma
Consuelo Torrini, Trang Nguyen, Chang Shu, et al.
Molecular Cell (2022) Vol. 82, Iss. 16, pp. 3061-3076.e6
Open Access | Times Cited: 70
Consuelo Torrini, Trang Nguyen, Chang Shu, et al.
Molecular Cell (2022) Vol. 82, Iss. 16, pp. 3061-3076.e6
Open Access | Times Cited: 70
New clinical trial design in precision medicine: discovery, development and direction
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms
Na Jia, Yunzhen Gao, Min Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Na Jia, Yunzhen Gao, Min Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 48
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 48
Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, et al.
Epigenomes (2023) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 42
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, et al.
Epigenomes (2023) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 42
Lysine lactylation in the regulation of tumor biology
Zijian Yang, Yingqi Zheng, Qiang Gao
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 720-731
Closed Access | Times Cited: 28
Zijian Yang, Yingqi Zheng, Qiang Gao
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 720-731
Closed Access | Times Cited: 28
A novel deacetylase inhibitor KLX suppresses liver fibrosis by deacetylating PPARγ through promoting ubiquitination-mediated HDAC1 degradation
Feng Zhang, Jinglun Song, Han Wu, et al.
Science China Life Sciences (2025)
Closed Access | Times Cited: 2
Feng Zhang, Jinglun Song, Han Wu, et al.
Science China Life Sciences (2025)
Closed Access | Times Cited: 2
Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma
Chuanjie Zhang, Li Chen, Yihan Liu, et al.
Theranostics (2021) Vol. 11, Iss. 8, pp. 3676-3693
Open Access | Times Cited: 93
Chuanjie Zhang, Li Chen, Yihan Liu, et al.
Theranostics (2021) Vol. 11, Iss. 8, pp. 3676-3693
Open Access | Times Cited: 93
Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer
Miaomiao Huo, Jingyao Zhang, Wei Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 59
Miaomiao Huo, Jingyao Zhang, Wei Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 59
The Effect of Oxidative Phosphorylation on Cancer Drug Resistance
Ziyi Zhao, Yong Mei, Ziyang Wang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 62-62
Open Access | Times Cited: 56
Ziyi Zhao, Yong Mei, Ziyang Wang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 62-62
Open Access | Times Cited: 56
Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression
Yunkuo Li, Yujie Pan, Xiaodong Zhao, et al.
Clinical Nutrition (2023) Vol. 43, Iss. 2, pp. 332-345
Open Access | Times Cited: 28
Yunkuo Li, Yujie Pan, Xiaodong Zhao, et al.
Clinical Nutrition (2023) Vol. 43, Iss. 2, pp. 332-345
Open Access | Times Cited: 28
Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme
Jolie Bou-Gharios, G. Noël, Hélène Burckel
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 11
Jolie Bou-Gharios, G. Noël, Hélène Burckel
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 11
Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
Cristina Trejo‐Solís, Rosa Angélica Castillo‐Rodríguez, Norma Serrano‐García, et al.
Metabolites (2024) Vol. 14, Iss. 5, pp. 249-249
Open Access | Times Cited: 10
Cristina Trejo‐Solís, Rosa Angélica Castillo‐Rodríguez, Norma Serrano‐García, et al.
Metabolites (2024) Vol. 14, Iss. 5, pp. 249-249
Open Access | Times Cited: 10
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
Dimitris Karagiannis, Θεόδωρος Ράμπιας
Cancers (2021) Vol. 13, Iss. 14, pp. 3575-3575
Open Access | Times Cited: 54
Dimitris Karagiannis, Θεόδωρος Ράμπιας
Cancers (2021) Vol. 13, Iss. 14, pp. 3575-3575
Open Access | Times Cited: 54
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
Jacob King, Maya Patel, Sriram Chandrasekaran
Metabolites (2021) Vol. 11, Iss. 11, pp. 792-792
Open Access | Times Cited: 46
Jacob King, Maya Patel, Sriram Chandrasekaran
Metabolites (2021) Vol. 11, Iss. 11, pp. 792-792
Open Access | Times Cited: 46
Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona
Yang He, Yuefei Fang, Meng Zhang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 2057-2073
Open Access | Times Cited: 41
Yang He, Yuefei Fang, Meng Zhang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 2057-2073
Open Access | Times Cited: 41
TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma
Shixue Yang, Jixing Zhao, Xiaoteng Cui, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 7032-7050
Open Access | Times Cited: 36
Shixue Yang, Jixing Zhao, Xiaoteng Cui, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 7032-7050
Open Access | Times Cited: 36
HDACs and the epigenetic plasticity of cancer cells: Target the complexity
Claudio Brancolini, Teresa Gagliano, Martina Minisini
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108190-108190
Open Access | Times Cited: 31
Claudio Brancolini, Teresa Gagliano, Martina Minisini
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108190-108190
Open Access | Times Cited: 31
Epigenetic Underpinnings of Inflammation: A Key to Unlock the Tumor Microenvironment in Glioblastoma
Nian Chen, Cheng Peng, Dan Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Nian Chen, Cheng Peng, Dan Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Targeting glycolysis for cancer therapy using drug delivery systems
Yongzhuo Huang
Journal of Controlled Release (2022) Vol. 353, pp. 650-662
Closed Access | Times Cited: 28
Yongzhuo Huang
Journal of Controlled Release (2022) Vol. 353, pp. 650-662
Closed Access | Times Cited: 28
Ultrasound‐Activatable g‐C3N4‐Anchored Titania Heterojunction as an Intracellular Redox Homeostasis Perturbator for Augmented Oncotherapy
Mengting He, Honglian Yu, Yinmin Zhao, et al.
Small (2023) Vol. 19, Iss. 21
Closed Access | Times Cited: 16
Mengting He, Honglian Yu, Yinmin Zhao, et al.
Small (2023) Vol. 19, Iss. 21
Closed Access | Times Cited: 16
Nanoparticle-Based Treatment in Glioblastoma
Diogo Roque, Nuno Cruz, Hugo Alexandre Ferreira, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1328-1328
Open Access | Times Cited: 16
Diogo Roque, Nuno Cruz, Hugo Alexandre Ferreira, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1328-1328
Open Access | Times Cited: 16
